Minister for Health and Active Ageing Jo Etienne Abela announced that with an investment of €155,000 per year, around 1,600 people will begin to benefit from the use of free EpiPens for patients with serious allergy problems.
Minister Abela said that Epi-Pen is a crucial medicine that contains epinephrine. It was stated that this medicine is used by children to adults who may experience a severe allergic reaction, known as anaphylaxis, caused by food, medicine or insect stings among others and in some cases, anaphylaxis can cause death. A medicine that is very expensive but necessary, so much so that some people have to carry one with them wherever they go.
The minister explained that through this medical equipment, people who experience a severe allergic reaction will be able to respond to it with a measure that will strengthen safety and access to care.
"This is another important, indeed revolutionary, step that demonstrates how seriously the Government takes the quality of life and the lives of every individual in our society. Therefore, the Government is committed to continuing to introduce medicines into the government formulary for the benefit of Maltese and Gozitan patients," concluded Dr Abela.
Photo: MHA
We use essential cookies to run the site. With your permission we may also
use analytics cookies to understand how the news is read.
Privacy & cookies
Get the Live News Malta app
Add Live News Malta to your home screen for one-tap access.
Welcome to the New Live News Malta! 🇲🇹
We’re excited to welcome you to the newly revamped Live News Malta, bringing you a fresh look, a better experience, and an easier way to stay informed about what’s happening across Malta and Gozo.
We’ve redesigned the website to make it faster, cleaner, and easier to navigate, whether you're catching up on the latest headlines, exploring local stories, or simply taking a break with our new Crosswords and Word Search games.
We’ll continue introducing new features and improvements to make Live News Malta even better.
Take a look around, explore what’s new, and let us know what you think!